Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

Amy Esler; Amy Hewitt; Jennifer Hall-Lande; Sandra L. Pettingell; James Houseworth

doi:10.1007/s10803-019-03903-7

Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

Amy Esler, Amy Hewitt, Jennifer Hall-Lande, Sandra L. Pettingell, James Houseworth

Research output: Contribution to journal › Article › peer-review

14 Scopus citations

Abstract

Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

Original language	English (US)
Pages (from-to)	2291-2303
Number of pages	13
Journal	Journal of Autism and Developmental Disorders
Volume	49
Issue number	6
DOIs	https://doi.org/10.1007/s10803-019-03903-7
State	Published - Jun 15 2019

Bibliographical note

Funding Information:
Funding This publication is supported by Grant #90RT5019-01-01 at the Research and Training Center for Community Living from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR), U.S. Department of Health and Human Services; Grant # 90IF0101-03-00, United States Department of Health and Human Services (USDHHS), Administration on Community Living, Administration on IDD; and the University of Minnesota Leadership Education in Neurodevelopmental and Related Disabilities (MNLEND) Program, U.S. Maternal and Child Health Bureau (MCHB), Grant 5 T73MC12835-09-00. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not therefore necessarily represent official NIDILRR, USDHHS, or MCHB policy.

Publisher Copyright:
© 2019, Springer Science+Business Media, LLC, part of Springer Nature.

Keywords

ASD
Autism spectrum disorder
Community living
ID
Intellectual and developmental disabilities
National core indicators
Psychotropic medications

Access

10.1007/s10803-019-03903-7

OpenUrl availability

Full text

Cite this

Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States. / Esler, Amy ; Hewitt, Amy; Hall-Lande, Jennifer et al.
In: Journal of Autism and Developmental Disorders, Vol. 49, No. 6, 15.06.2019, p. 2291-2303.

Research output: Contribution to journal › Article › peer-review

@article{a9e011fd0db64612b21f922907b59224,

title = "Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States",

abstract = "Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.",

keywords = "ASD, Autism spectrum disorder, Community living, ID, Intellectual and developmental disabilities, National core indicators, Psychotropic medications",

author = "Amy Esler and Amy Hewitt and Jennifer Hall-Lande and Pettingell, {Sandra L.} and James Houseworth",

note = "Funding Information: Funding This publication is supported by Grant #90RT5019-01-01 at the Research and Training Center for Community Living from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR), U.S. Department of Health and Human Services; Grant # 90IF0101-03-00, United States Department of Health and Human Services (USDHHS), Administration on Community Living, Administration on IDD; and the University of Minnesota Leadership Education in Neurodevelopmental and Related Disabilities (MNLEND) Program, U.S. Maternal and Child Health Bureau (MCHB), Grant 5 T73MC12835-09-00. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not therefore necessarily represent official NIDILRR, USDHHS, or MCHB policy. Publisher Copyright: {\textcopyright} 2019, Springer Science+Business Media, LLC, part of Springer Nature.",

year = "2019",

month = jun,

day = "15",

doi = "10.1007/s10803-019-03903-7",

language = "English (US)",

volume = "49",

pages = "2291--2303",

journal = "Journal of Autism and Developmental Disorders",

issn = "0162-3257",

publisher = "Springer New York",

number = "6",

}

TY - JOUR

T1 - Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

AU - Esler, Amy

AU - Hewitt, Amy

AU - Hall-Lande, Jennifer

AU - Pettingell, Sandra L.

AU - Houseworth, James

N1 - Funding Information: Funding This publication is supported by Grant #90RT5019-01-01 at the Research and Training Center for Community Living from the National Institute on Disability Independent Living and Rehabilitation Research (NIDILRR), U.S. Department of Health and Human Services; Grant # 90IF0101-03-00, United States Department of Health and Human Services (USDHHS), Administration on Community Living, Administration on IDD; and the University of Minnesota Leadership Education in Neurodevelopmental and Related Disabilities (MNLEND) Program, U.S. Maternal and Child Health Bureau (MCHB), Grant 5 T73MC12835-09-00. Grantees undertaking projects under government sponsorship are encouraged to express freely their findings and conclusions. Points of view or opinions do not therefore necessarily represent official NIDILRR, USDHHS, or MCHB policy. Publisher Copyright: © 2019, Springer Science+Business Media, LLC, part of Springer Nature.

PY - 2019/6/15

Y1 - 2019/6/15

N2 - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

AB - Individuals with autism spectrum disorder (ASD) have higher rates of co-occurring diagnoses and use of psychotropic medication prescriptions than people with other developmental disabilities. Few studies have examined these trends in samples of people with intellectual and developmental disabilities (IDD) with and without ASD. Using a random sample of 11,947 adult IDD service users from 25 states, co-occurring diagnoses and psychotropic medication use were compared for those with and without ASD. Regardless of diagnosis, individuals with ASD had higher percentages of psychotropic medication use. Controlling for co-occurring condition, age, gender, and ID level, a diagnosis of ASD predicted number of medications used. Further research is needed to understand why individuals with ASD are prescribed more medication, more often, than similarly functioning groups of individuals without ASD.

KW - ASD

KW - Autism spectrum disorder

KW - Community living

KW - ID

KW - Intellectual and developmental disabilities

KW - National core indicators

KW - Psychotropic medications

UR - http://www.scopus.com/inward/record.url?scp=85060916786&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060916786&partnerID=8YFLogxK

U2 - 10.1007/s10803-019-03903-7

DO - 10.1007/s10803-019-03903-7

M3 - Article

C2 - 30706350

AN - SCOPUS:85060916786

SN - 0162-3257

VL - 49

SP - 2291

EP - 2303

JO - Journal of Autism and Developmental Disorders

JF - Journal of Autism and Developmental Disorders

IS - 6

ER -

Psychotropic Medication Use for Adults with Autism Spectrum Disorder who Receive Services and Supports Through Adult Developmental Disability Services in the United States

Abstract

Bibliographical note

Keywords

Access

OpenUrl availability

Other files and links

Fingerprint

Cite this